CEL-SCI Corporation (CVM)
NYSEAMERICAN: CVM · Real-Time Price · USD
1.520
+0.160 (11.76%)
At close: Aug 5, 2026, 4:00 PM EDT
1.510
-0.010 (-0.66%)
After-hours: Aug 5, 2026, 6:31 PM EDT
CEL-SCI Market Cap
CEL-SCI has a market cap or net worth of $26.57 million as of August 5, 2026. Its market cap has decreased by -57.90% in one year.
Market Cap
26.57M
Enterprise Value
33.18M
1-Year Change
-57.90%
Ranking
Category
Stock Price
$1.52
ChartMarket Cap Chart
Since February 10, 1992, CEL-SCI's market cap has decreased from $126.81M to $26.57M, a decrease of -79.05%. That is a compound annual growth rate of -4.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 26.57M | -39.94% |
| Dec 31, 2025 | 44.23M | 49.58% |
| Dec 31, 2024 | 29.57M | -78.25% |
| Dec 29, 2023 | 135.95M | 32.44% |
| Dec 30, 2022 | 102.65M | -66.57% |
| Dec 31, 2021 | 307.04M | -33.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABVC BioPharma | 27.04M |
| Quince Therapeutics | 26.81M |
| Actuate Therapeutics | 26.80M |
| Actinium Pharmaceuticals | 25.41M |
| IGC Pharma | 24.82M |
| Evaxion | 24.60M |
| Longeveron | 23.45M |
| Barinthus Biotherapeutics | 23.07M |